Cord blood ceramides facilitate early risk identification into childhood metabolic health

Natl Sci Rev. 2024 Oct 3;11(10):nwae352. doi: 10.1093/nsr/nwae352. eCollection 2024 Oct.

Jia Zheng^{1

2}, Sin Man Lam^{3

4}, Binhua Jiang⁴, Lili Mao², Jieying Liu², Qian Zhang², Miao Yu², Wei Ling Florence Lim⁴, Claudia H T Tam⁵, William L Lowe Jr⁶, Wing Hung Tam⁷, Ying Gao¹, Junqing Zhang¹, Ronald C W Ma⁵, Xinhua Xiao², Guanghou Shui^{3

8}

¹ Department of Endocrinology, Peking University First Hospital, China.
² Key Laboratory of Endocrinology of National Health Commission, Diabetes Research Center of Chinese Academy of Medical Sciences, Department of Endocrinology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, China.
³ State Key Laboratory of Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, China.
⁴ LipidALL Technologies Company Limited, China.
⁵ Department of Medicine and Therapeutics; Hong Kong Institute of Diabetes and Obesity, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, China.
⁶ Northwestern University Feinberg School of Medicine, USA.
⁷ Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, China.
⁸ University of Chinese Academy of Sciences, China.

No abstract available